Is bemotrizinol safe?

Bemotrizinol has been used in Europe, Japan, Australia, and other markets for approximately 20 years. It has an extensive global safety profile, which forms the basis of the current FDA review process.

Why does the US need a new UV filter when sunscreens already exist?

Only 8 of the 16 FDA-approved UV filters are commonly used in US products. Europe and Japan have approved over 30 filters, enabling superior formulations. Fewer ingredients mean trade-offs in texture, stability, and protection coverage.

When will products with bemotrizinol be available in the US?

FDA approval is expected sometime in 2026. After approval, manufacturers will need time to develop and release new formulations, so products could appear in late 2026 to 2027.

Bemotrizinol Could Become the First New UV Filter Approved in the US in Decades

Bemotrizinol (BEMT) is a broad-spectrum UV filter that blocks both UVA and UVB radiation. It has been approved and widely used in Europe, Japan, and Australia for roughly 20 years, yet it has never been available in the United States. In 2026, it stands to become the first new UV filter approved by the FDA in decades.

The US Sunscreen Gap

The FDA has approved 16 UV filters in total, but only 8 are commonly used in commercial sunscreen products. Compare that to Europe and Japan, where over 30 UV filters are approved, giving formulators a far wider palette.

This isn’t just a numbers problem. Fewer ingredients mean real limitations in texture, photostability, and protection breadth. The heavy, white-cast sunscreens that many US consumers have grown accustomed to are partly a consequence of this restricted ingredient pool.

Why Bemotrizinol Stands Out

Kelly Dobos, a cosmetic chemist at the University of Cincinnati, describes bemotrizinol as a generational leap.

“It stays stable longer and gives better broad-spectrum protection than any sunscreen filter currently approved in the US.”

Three properties set bemotrizinol apart from the current US lineup.

Photostability: It resists degradation under UV exposure. Some existing US filters, notably avobenzone, break down when exposed to sunlight, reducing protection over time.
True broad-spectrum coverage: It absorbs across both UVA and UVB wavelengths. Most current US filters excel in one range but underperform in the other.
Formulation flexibility: It blends well with other UV filters, allowing manufacturers to create lighter, more transparent products without sacrificing SPF.

What This Means for Consumers

Bemotrizinol approval would represent a structural shift in the US sunscreen market. Manufacturers could design products that are thinner, more stable, and more protective than what current ingredients allow.

Until now, US consumers who wanted the elegance and broad protection of European or Japanese sunscreens had to rely on imports. With bemotrizinol in the toolbox, domestically formulated US sunscreens could match global benchmarks for the first time.

Timeline and Outlook

The FDA has not announced a specific approval date, but a decision is expected within 2026. Even after approval, manufacturers will need development time for new formulations. Consumers can realistically expect bemotrizinol-containing US sunscreens to appear between late 2026 and 2027.

A UV filter with two decades of global use is finally arriving in the US. For anyone who has ever wondered why American sunscreens lag behind their international counterparts, this is the ingredient that closes the gap.

Source: University of Cincinnati